These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1825127)

  • 41. Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension.
    Kohno M; Fukui T; Horio T; Yokokawa K; Yasunari K; Yoshiyama M; Kurihara N; Takeda T
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R451-7. PubMed ID: 8141402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased secretion of brain natriuretic peptide and atrial natriuretic peptide, but not sufficient to induce natriuresis in rats with nephrotic syndrome.
    Yokota N; Yamamoto Y; Aburaya M; Kitamura K; Eto T; Kangawa K; Minamino N; Matsuo H; Tanaka K
    Biochem Biophys Res Commun; 1991 Jan; 174(1):128-35. PubMed ID: 1824917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the action of atriopeptin III on renal function in normal and DOCA-salt hypertensive rats.
    Johns EJ; Rutkowski B
    J Hypertens; 1989 Aug; 7(8):675-82. PubMed ID: 2530272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: comparative receptor localization and changes in different hypertension models in the rat.
    Wilson SK; Lynch DR; Ladenson PW
    Endocrinology; 1989 Jun; 124(6):2799-808. PubMed ID: 2542000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Body fluid distribution in the maintenance of DOCA-salt hypertension in rats.
    Tajima Y; Ichikawa S; Sakamaki T; Matsuo H; Aizawa F; Kogure M; Yagi S; Murata K
    Am J Physiol; 1983 May; 244(5):H695-700. PubMed ID: 6846557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Ma SK; Kim SW
    Regul Pept; 2009 Oct; 157(1-3):76-83. PubMed ID: 19422859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during postnatal development.
    Kuroski de Bold ML
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):1006-18. PubMed ID: 9715795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of chronic treatment with deoxycorticosterone acetate on content of a natriuretic substance in atria of rats.
    Hathaway SJ; Fregly MJ; Wilson KM; Papanek PE; Henley WN
    Proc Soc Exp Biol Med; 1986 Oct; 183(1):92-8. PubMed ID: 2944121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamic studies in DOCA-salt hypertensive rats after opening of an arteriovenous fistula.
    Huang M; Hester RL; Guyton AC; Norman RA
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1802-8. PubMed ID: 1621839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression of natriuretic peptide receptors in rats with DOCA-salt hypertension.
    Nuglozeh E; Mbikay M; Stewart DJ; Legault L
    Am J Physiol; 1997 Oct; 273(4):C1427-34. PubMed ID: 9357789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
    Klarr SA; Keep RF; Betz AL
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies on the pressor mechanism of 19-hydroxyandrostenedione].
    Honda M; Minato M; Takayama R; Nagashima Y; Watanabe M; Izumi Y; Fukuda N; Soma M; Shiratsuchi T; Watanabe Y
    Nihon Naibunpi Gakkai Zasshi; 1989 Jan; 65(1):18-31. PubMed ID: 2524410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atrial natriuretic peptide in plasma, atria, ventricles, and hypothalamus of Long-Evans and vasopressin-deficient Brattleboro rats.
    Ruskoaho H; Taskinen T; Pesonen A; Vuolteenaho O; Leppäluoto J; Tuomisto L
    Endocrinology; 1989 May; 124(5):2595-603. PubMed ID: 2523304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Up-regulation of adrenal cortical and medullary atrial natriuretic peptide and gene expression in rats with deoxycorticosterone acetate-salt treatment.
    Lai FJ; Shin SJ; Lee YJ; Lin SR; Jou WY; Tsai JH
    Endocrinology; 2000 Jan; 141(1):325-32. PubMed ID: 10614654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
    Ndisang JF; Jadhav A
    J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.